A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

Ozempic has FDA approval to treat type 2 diabetes. Wegovy has approval to help people lose weight when they have both obesity and weight-related health problems. Ozempic and Wegovy are part of a ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Proponents say long-term savings could outweigh the cost — especially in West Virginia, which has the nation's highest rates ...

Patients waiting for NHS weight loss jabs are buying potentially unsafe jabs online or from gyms and beauty salons ...

People using weight loss drugs like Ozempic are saving hundreds of dollars on groceries each year, according to a new study.